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SUMMARY
Argon plasma coagulation (APC) is one of the interventional pulmonology techniques primarily aimed at the treatment of 
hemoptysis. It represents a form of non contact electrosurgey that uses ionized argon gas in order to produce electrical current 
that affects soft tissues. APC is reported to be effective in the treatment of early stage lung cancer, in the treatment of benign 
granulation tissue surrounding tracheal stents and in palliative treatment of malignant airway obstruction. Major indication for 
APC is hemostasis in severe hemoptysis, it can also be used as an alternative technique for laser resection or electrocautery, 
in urgent removal of tumors situated in large airways. The present article reports successful use of APC in the treatment of 
centrally located squamous cell lung cancer that caused complete right lung atelectasis. The use of APC led to complete 
reexpansion of the right lung and improvement in dyspnoea and chest discomfort of the patient. Significant improvement was 
observed in lung function parameters and blood gas analysis. With the use of APC solid tumor was completely removed from 
the right main bronchus and airway integrity was restored. From this case we can conclude that APC can be safely and suc-
cessfully used for urgent debulking of malignant central airway obstruction.
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INTRODUCTION
Argon plasma coagulation (APC) is one of the interventional pulmonology 
techniques with immediate effect aimed at urgent debulking of major airways. 
APC is a form of non contact electrosugrery that uses argon gas ionized into 
plasma in order to accomplish coagulative tissue effect (1,2). Created electri-
cal current, affects soft tissues in the form of heat and, leads to coagulation. 
Argon plasma seeks the way of least resistance and that is why it affects soft 
spots on the mucosal surface, however with the appearance of coagulated 
tissue electrical resistance to current rises, and argon plasma affects the 
target tissue with less effect. That is the reason why this procedure is, in a 
way, self limiting. Removal of coagulated masses with the use of forceps or 
suction is necessary to proceed with the airway debulking. 
Equipment needed for APC consists of high frequency electrical generator, 
insulated  flexible  bronchoscope  (recommendable  with  ceramic  tip),  rigid 
bronchoscope, grounding plate, different sets of APC probes and a tank with 
argon gas. Various effects on the target tissue are accomplished with the 
adjustment of argon gas flow, time of application and power setting. Settings 
usually  used  for  coagulation  include  power  at  30-80W,  burst  time  3  sec 
and argon flow up to 2L/min (3,4). In order to create electrical current and 
tissue effect the tip of the probe for APC must be less than 1 cm from the 
target tissue. The tip of the probe must protrude at least one cm away from 
the tip of the bronchoscope in order to avoid instrument damage. European 
Respiratory  Society,  American  Thoracic  Society  and  American  College 
of  Chest  Physicians  published  guidelines  for  interventional  pulmonology 
procedures including argon plasma coagulation (5,6). APC can be carried 
out  via  flexible  bronchoscopy  alone,  or  combination  of  flexible  and  rigid 
bronchoscopy. The latter combination ensures better ventilation of the patient 
and  better  visualization  of  target  tissue.  Usually  APC  is  performed  under 
general anesthesia, such procedure requires specific precaution measures 
which include: oxygen concentration under 40%, proper grounding, avoiding 
of flammable materials (silicone and hybrid tracheobronchial stents, endotra-
cheal tube) (1-3). Major indications for APC include: palliative debulking of 
malignant endobronchial masses, treatment of benign endobronchial tumors, 
and  treatment  of  unresectable  or  inoperable  postintubation,  postresection 
and  posttransplantation  tracheobronchial  stenoses.  APC  is  indicated  as 
curative technique for visible superficial lung cancer (carcinoma in situ or 
microinvasive lung cancer). The only absolute contraindication is extraluminal 
compression,  relative  contraindications  include:  hemodynamic  instability, 
shock,  unresolved  coagulopathies,  arrhythmias,  recent  acute  myocardial 
infarction. Complications of APC include bleeding, airway burns, perforation, 
pneumothorax, pneumomediastinum and restenosis (5,6).
As a technique for urgent debulking of large malignant masses in the airways 
APS has proven to be more than successful. However in some of the urgent 
conditions, as hemoptysis (usually due to lung cancer), APC is most preferable 
technique. With the help of APC airway bleeding can be stopped in matter of min-
utes. That is how this life threatening condition can be comfortably resolved.
The competency standards required for practicing APC include experience 
with flexible and rigid bronchoscopy; trainees must perform at least 10 pro-
cedures under supervision. In order to maintain competence 10 procedures 
per year must be performed (5-6).
CASE REPORT
A 58-year old patient was admitted to hospital for diagnostic evaluation of 
solid tumorous mass situated in the upper right lobe. CT scan of the thorax 
performed during previous hospitalization in the regional hospital revealed 
homogeneous solid infiltration of the abovementioned localization. At the time 
of admission the patient was in good general condition, complaining of dry 
cough, dyspnoea, malaise, weakness and loss of appetite. Partial respiratory 
insufficiency was verified by blood gas analysis (PaO2 7.72 KPa, PaCO2 4.91 
KPa, SaO2 90.7%, PaO2 – oxygen partial pressure in arterial blood, PaCO2 
– carbon dioxide partial pressure in arterial blood, SaO2 – oxygen saturation 
of arterial blood). Lung function tests revealed mixed (obstructive and restric-
tive) disorder of ventilation, with total resistance in airways (RAW) 0.35, vital 
capacity (VC) 57.1%, forced vital capacity (FVC) 59.9%, forced expiratory 
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volume in first second (FEV1) 46.9%. Chest X ray (CXR) of the thorax showed 
solid infiltrative shadow in the projection of right upper lobe and shadow of 
pleural effusion on the right hemithorax. Thoracocenthesis was performed, 
cytology examination of pleural effusion revealed mixed cellular composition. 
Diagnostic  bronchoscopy  followed,  endoscopic  finding  verified  tumorous 
infiltration of the distal part of trachea extending to the right main bronchus. 
Biopsy of the infiltration confirmed squamous cell carcinoma. In the following 
treatment  Nd:YAG  laser  resection  in  combination  with  brachytherapy  was 
indicated. The patient was further treated due to respiratory insufficiency and 
infection. Nine days after diagnostic bronchoscopy the patient complains on 
chest discomfort, pain and severe dyspnoea. Physical examination revealed 
diminished breathing on the right chest side, tachypnoea and tachycardia. 
Complete right lung atelectasis was seen on CXR (Figure 1). 
Figure 1A Complete right lung atelectasis, and 1B Reopening of the right main 
bronchus after the APC led to the resolution of right lung atelectasis
Blood gas analysis was aggravated, global respiratory insufficiency manifested, 
with PO2 6.7 kPa, PCO2 6.6 kPa, SaO2 84%. Lung function test were worsened 
too, with increase in obstruction (RAW 0.55) and restriction (VC 48%, FVC 46%, 
FEV1 38%). Urgent bronchoscopy was performed, and was confirmative for 
tumor penetration and obturation of the right main bronchus. Indication for appli-
cation of interventional pulmonology technique for immediate desobstruction 
followed. Considering the fact that at the moment only available interventional 
technique was argon plasma coagulation, it was decided to perform APC in 
order to restore airway patency and reopen right main bronchus.
APC was performed using the probe, an argon gas source and electrosurgical 
unit Endoplasma PSD-60 (Olympus). Technique was conducted under general 
anesthesia using combination of flexible and rigid bronchoscopy. Patient was 
previously  premedicated  using  midazolam  and  fentanyl,  propofol  induced 
general  anesthesia  followed.  Flexible  bronchoscope  (Olympus  T60)  was 
introduced via rigid Friedel’s rigid bronchoscope. Combination of these two 
techniques allows better ventilation and introduction of forceps for removal 
of coagulated debris. Initial APC setting included power of 25W, argon gas 
flow 0.8 L/min and application time of burst of average 3 sec. Bronchoscopic 
scheme before and after intervention is presented on Figure 2. Figure 3 is 
endoscopic image of APC burst in the distal part of the trachea.
Figure 2. Scheme of bronchoscpic findings before (A) and after APC (B).
Figure 3. APC burst in the distal part of the trachea surrounded with coagulated 
necrotic debris.
During the procedure that lasted 45 minutes necrotic debris was removed with 
forceps and suction. Inspiratory oxygen fraction was kept under 40% in order 
to avoid airway fire. After the procedure and removal of the debris, airway 
integrity was restored. Brochoscopic finding confirmed reopening of the distal 
part of the trachea and right main bronchus. We have accomplished complete 
reaerisation of the right lung and resolving of atelectasis. CXR after the APC 
application is shown on figure 1B.
After the APC we have observed significant improvement in arterial blood gases 
analysis and disappearance of respiratory failure (PaO2 9.77 kPa, PaCO2 4.70 
kPa, SaO2 93.8%). Lung function tests improved also significantly, obstructive 
component was completely resolved (RAW 0.28) and restrictive component 
was improved.
Control  bronchoscopy  was  performed  2  weeks  after  the  APC  treatment, 
after 2 additional weeks at the moment of insertion of the first catheter for 
brachytherapy and then after one month during the insertion of a catheter for 
the second brachytherapy treatment.
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In further course of the treatment patient received complete brachytherapy 
(two fractions of 7 Gy each) and chemotherapy (cisplatin plus etoposide), 
followed by split course external beam radiotherapy. 
DISCUSSION
Numerous  studies  report  successful  use  of  APC  in  the  treatment  of  non 
malignant CAO. That treatment usually means coagulation of benign granula-
tion tissue of various origins. Keller et al. report 5 cases of successful use of 
APC in the treatment of airway complications after solid organ transplantation 
(7). Sato et al in 2000 have reported successful use of APC and Tranilast (an 
antiallergic agent used to prevent hypertrophic scars and keloid) in the treat-
ment of granulation tissue obstructing the airways after tracheal anostomosis 
(8). Recent in vitro study conducted by Colt et al. confirmed usefulness and 
safety of APC use in the presence of airway stents. In this study APC setting 
that included power at 40W, argon gas flow of 0.8 L/min and FiO2 21%, was 
the safest one (9). Yasuo et al. used APC in the treatment of postintubation tra-
cheal stenoses in patients who were inoperable or had unresectable disease or 
refused surgery for personal reasons. In this study it was pointed that success-
ful treatment required repeated use of APC (2-3 times in a few weeks) (10).
There are not too many reports of successful use of APC in urgent debulking 
of malignant CAO. As stated earlier, APC is recommended for the treatment 
of hemoptysis or in some cases for the treatment of early stage lung cancer. 
Vonk-Noordegraaf et al. (11) published a study that evaluates bronchoscopic 
treatment of radiographically occult lung cancer (ROLC). They have evaluated 
the effects of Nd:YAG laser resection, electrocautery and APC in the treatment 
of ROLC. Only two of their patients were treated with APC, and the data on the 
outcome of these patients is lacking. However in that study the success rate of 
bronchoscopic treatment is 97%, compared to 70% success rate for surgical 
treatment in stage I lung cancer. Cappacio et al. (12) reported effective use 
of APC in the treatment of centrally located malignant melanoma metastases; 
reminding us of palliative APC use. The effectiveness of APC in palliative treat-
ment of lung cancer has been reported in several studies. Morice et al. (13) 
used APC to treat hemoptysis and central airway obstruction (CAO), prompt 
relief of symptoms was achieved in all but one patient and mean follow up for 
hemoptysis was 97±92 days and for dyspnoea 53 days. Major indication for 
APC in study conducted by Reichle et al. (14) was airway obstruction (186 pts, 
51%) and hemoptysis (119 pts, 33%), they have performed 482 interventions, 
with overall success rate of 67% (full or partial recanalization, hemostasis, 
or both). Success rate of 91% in the treatment of airway obstruction and 
hemoptysis is reported from Crosta et al. (15), however in order to obtain this 
success rate of mean 3.5 interventions per patient was required. 
All of the studies that have evaluated the use of APC in the palliative treatment of 
lung cancer suggest that this technique is safe and efficient. Our case report con-
firms that APC can and should be utilized as a technique for urgent reopening of 
major airways. When other procedures are not available (such as laser resection 
or electrocautery) APC can be safely used for endobronchial tumor resection.
CONCLUSION
Argon plasma coagulation may be used as an alternative to laser resection or 
electrocautery in the treatment of malignant CAO. If used by experienced bron-
choiscopist and with all precaution measures taken, APC can be performed 
without any complications. In regard to the published guidelines, APC should 
be more popularized as a technique for urgent debulking of central airways.
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